US FDA refuses to approve Merck’s selective relaxa..

Criou um novo artigo

2 anos

US FDA refuses to approve Merck’s selective relaxant binding agent | #general Anesthetic Effect Drugs Development Market

US FDA refuses to approve Merck’s selective relaxant binding agent

The report provides comprehensive information on the therapeutics under development for General Anesthetic Effect, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive

Curtir

Comentario

Compartilhar